119 related articles for article (PubMed ID: 14712485)
1. Fine mapping of chromosome 22q tumor suppressor gene candidate regions in astrocytoma.
Hartmann C; Nümann A; Mueller W; Holtkamp N; Simon M; von Deimling A
Int J Cancer; 2004 Mar; 108(6):839-44. PubMed ID: 14712485
[TBL] [Abstract][Full Text] [Related]
2. Allelic losses at 1p36 and 19q13 in gliomas: correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene.
Barbashina V; Salazar P; Holland EC; Rosenblum MK; Ladanyi M
Clin Cancer Res; 2005 Feb; 11(3):1119-28. PubMed ID: 15709179
[TBL] [Abstract][Full Text] [Related]
3. Frequent LOH on 22q12.3 and TIMP-3 inactivation occur in the progression to secondary glioblastomas.
Nakamura M; Ishida E; Shimada K; Kishi M; Nakase H; Sakaki T; Konishi N
Lab Invest; 2005 Feb; 85(2):165-75. PubMed ID: 15592495
[TBL] [Abstract][Full Text] [Related]
4. Loss of heterozygosity on chromosome 10q associated with malignancy and prognosis in astrocytic tumors, and discovery of novel loss regions.
Daido S; Takao S; Tamiya T; Ono Y; Terada K; Ito S; Ouchida M; Date I; Ohmoto T; Shimizu K
Oncol Rep; 2004 Oct; 12(4):789-95. PubMed ID: 15375501
[TBL] [Abstract][Full Text] [Related]
5. Combined molecular genetic studies of chromosome 22q and the neurofibromatosis type 2 gene in central nervous system tumors.
Ng HK; Lau KM; Tse JY; Lo KW; Wong JH; Poon WS; Huang DP
Neurosurgery; 1995 Oct; 37(4):764-73. PubMed ID: 8559307
[TBL] [Abstract][Full Text] [Related]
6. Common regions of deletion on chromosome 22q12.3-q13.1 and 22q13.2 in human astrocytomas appear related to malignancy grade.
Ino Y; Silver JS; Blazejewski L; Nishikawa R; Matsutani M; von Deimling A; Louis DN
J Neuropathol Exp Neurol; 1999 Aug; 58(8):881-5. PubMed ID: 10446812
[TBL] [Abstract][Full Text] [Related]
7. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas.
Jeng YM; Hsu HC
Int J Cancer; 2003 Jul; 105(5):625-9. PubMed ID: 12740910
[TBL] [Abstract][Full Text] [Related]
8. Complex chromosome 22 rearrangements in astrocytic tumors identified using microsatellite and chromosome 22 tile path array analysis.
Seng TJ; Ichimura K; Liu L; Tingby O; Pearson DM; Collins VP
Genes Chromosomes Cancer; 2005 Jun; 43(2):181-93. PubMed ID: 15770670
[TBL] [Abstract][Full Text] [Related]
9. The retinoblastoma gene is involved in malignant progression of astrocytomas.
Henson JW; Schnitker BL; Correa KM; von Deimling A; Fassbender F; Xu HJ; Benedict WF; Yandell DW; Louis DN
Ann Neurol; 1994 Nov; 36(5):714-21. PubMed ID: 7979217
[TBL] [Abstract][Full Text] [Related]
10. Loci associated with malignant progression in astrocytomas: a candidate on chromosome 19q.
von Deimling A; Bender B; Jahnke R; Waha A; Kraus J; Albrecht S; Wellenreuther R; Fassbender F; Nagel J; Menon AG
Cancer Res; 1994 Mar; 54(6):1397-401. PubMed ID: 8137236
[TBL] [Abstract][Full Text] [Related]
11. Molecular pathogenesis of pediatric astrocytic tumors.
Nakamura M; Shimada K; Ishida E; Higuchi T; Nakase H; Sakaki T; Konishi N
Neuro Oncol; 2007 Apr; 9(2):113-23. PubMed ID: 17327574
[TBL] [Abstract][Full Text] [Related]
12. Chromosome 10 and 17 deletions and p53 gene mutations in Thai patients with astrocytomas.
Put-Ti-Noi S; Petmitr S; Chanyavanich V; Sangruji T; Theerapuncharoen V; Hayashi K; Thangnipon W
Oncol Rep; 2004 Jan; 11(1):207-11. PubMed ID: 14654927
[TBL] [Abstract][Full Text] [Related]
13. Genetic alterations commonly found in diffusely infiltrating cerebral gliomas are rare or absent in pleomorphic xanthoastrocytomas.
Kaulich K; Blaschke B; Nümann A; von Deimling A; Wiestler OD; Weber RG; Reifenberger G
J Neuropathol Exp Neurol; 2002 Dec; 61(12):1092-9. PubMed ID: 12484572
[TBL] [Abstract][Full Text] [Related]
14. Identification of a human homolog of the Drosophila neuralized gene within the 10q25.1 malignant astrocytoma deletion region.
Nakamura H; Yoshida M; Tsuiki H; Ito K; Ueno M; Nakao M; Oka K; Tada M; Kochi M; Kuratsu J; Ushio Y; Saya H
Oncogene; 1998 Feb; 16(8):1009-19. PubMed ID: 9519875
[TBL] [Abstract][Full Text] [Related]
15. Loss of heterozygosity on chromosome 22 in human ependymomas.
Huang B; Starostik P; Kühl J; Tonn JC; Roggendorf W
Acta Neuropathol; 2002 Apr; 103(4):415-20. PubMed ID: 11904762
[TBL] [Abstract][Full Text] [Related]
16. A region of common deletion in 22q13.3 in human glioma associated with astrocytoma progression.
Oskam NT; Bijleveld EH; Hulsebos TJ
Int J Cancer; 2000 Feb; 85(3):336-9. PubMed ID: 10652423
[TBL] [Abstract][Full Text] [Related]
17. Absence of mutation of the p73 gene in astrocytic neoplasms.
Alonso ME; Bello MJ; Lomas J; Gonzalez-Gomez P; Arjona D; De Campos JM; Gutierrez M; Isla A; Vaquero J; Rey JA
Int J Oncol; 2001 Sep; 19(3):609-12. PubMed ID: 11494043
[TBL] [Abstract][Full Text] [Related]
18. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression.
Fults D; Brockmeyer D; Tullous MW; Pedone CA; Cawthon RM
Cancer Res; 1992 Feb; 52(3):674-9. PubMed ID: 1346255
[TBL] [Abstract][Full Text] [Related]
19. Chromosome 22q allelic losses at microsatellite loci in human astrocytic tumors.
Muhammad AK; Yoshimine T; Maruno M; Tokiyoshi K; Takemoto O; Hayakawa T
Neurol Med Chir (Tokyo); 1997 Aug; 37(8):606-10; discussion 611. PubMed ID: 9301196
[TBL] [Abstract][Full Text] [Related]
20. Human ependymomas reveal frequent deletions on chromosomes 6 and 9.
Huang B; Starostik P; Schraut H; Krauss J; Sörensen N; Roggendorf W
Acta Neuropathol; 2003 Oct; 106(4):357-62. PubMed ID: 12898154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
